Kymera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kymera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Kymera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $48.7M, a 12.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $48.7M -$6.98M -12.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $49.3M -$7.28M -12.9% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $52.9M +$44M +494% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $55M +$45.9M +507% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $55.7M +$46.5M +507% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $56.6M +$47.3M +508% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $8.91M -$517K -5.49% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $9.05M -$492K -5.16% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $9.18M -$467K -4.84% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $9.31M -$443K -4.54% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $9.43M -$419K -4.26% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $9.54M -$419K -4.21% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $9.65M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $9.75M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.85M -$8.44M -46.2% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $9.96M Sep 30, 2020 10-Q 2020-11-05
Q4 2019 $18.3M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.